Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
More America First Fees: US FDA Proposes GDUFA Facility Fee Waiver For Domestic Construction
Feb 06 2026
•
By
Derrick Gingery
The FDA wants to use GDUFA facility fees to encourage domestic manufacturing.
(Shutterstock)
More from Regulation
More from Policy & Regulation